158 related articles for article (PubMed ID: 15914848)
1. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
Lundstig A; Eliasson L; Lehtinen M; Sasnauskas K; Koskela P; Dillner J
J Gen Virol; 2005 Jun; 86(Pt 6):1703-1708. PubMed ID: 15914848
[TBL] [Abstract][Full Text] [Related]
2. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
[TBL] [Abstract][Full Text] [Related]
3. Simian virus 40 (SV40) and human cancer: a review of the serological data.
Shah KV; Galloway DA; Knowles WA; Viscidi RP
Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
[TBL] [Abstract][Full Text] [Related]
5. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
Viscidi RP; Rollison DE; Viscidi E; Clayman B; Rubalcaba E; Daniel R; Major EO; Shah KV
Clin Diagn Lab Immunol; 2003 Mar; 10(2):278-85. PubMed ID: 12626455
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of the human polyomaviruses.
Stolt A; Sasnauskas K; Koskela P; Lehtinen M; Dillner J
J Gen Virol; 2003 Jun; 84(Pt 6):1499-1504. PubMed ID: 12771419
[TBL] [Abstract][Full Text] [Related]
7. Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.
Taronna A; Mazzoni E; Corallini A; Bononi I; Pietrobon S; Guerra G; Palmonari C; Borgna-Pignatti C; Comar M; Bovenzi M; Casali F; Marci R; Rezza G; Barbanti-Brodano G; Tognon M; Martini F
PLoS One; 2013; 8(4):e61182. PubMed ID: 23634207
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.
Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pawlita M; Waterboer T; Neale RE
J Gen Virol; 2010 Jul; 91(Pt 7):1849-53. PubMed ID: 20219899
[TBL] [Abstract][Full Text] [Related]
9. Serological diagnosis of human polyomavirus infection.
Lundstig A; Dillner J
Adv Exp Med Biol; 2006; 577():96-101. PubMed ID: 16626030
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.
Sroller V; Hamšíková E; Ludvíková V; Vochozková P; Kojzarová M; Fraiberk M; Saláková M; Morávková A; Forstová J; Němečková S
J Med Virol; 2014 Sep; 86(9):1560-8. PubMed ID: 24214630
[TBL] [Abstract][Full Text] [Related]
11. Studies of neutralising antibodies to SV40 in human sera.
Minor P; Pipkin P; Jarzebek Z; Knowles W
J Med Virol; 2003 Jul; 70(3):490-5. PubMed ID: 12767016
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the occurrence of SV40 antibodies in South Africa.
Basetse HR; Lecatsas G; Gerber LJ
S Afr Med J; 2002 Oct; 92(10):825-8. PubMed ID: 12432810
[TBL] [Abstract][Full Text] [Related]
13. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples.
Kjaerheim K; Røe OD; Waterboer T; Sehr P; Rizk R; Dai HY; Sandeck H; Larsson E; Andersen A; Boffetta P; Pawlita M
Int J Cancer; 2007 Jun; 120(11):2459-65. PubMed ID: 17315193
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.
Rollison DE; Helzlsouer KJ; Alberg AJ; Hoffman S; Hou J; Daniel R; Shah KV; Major EO
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):460-3. PubMed ID: 12750243
[TBL] [Abstract][Full Text] [Related]
16. Serological cross reactivity between polyomavirus capsids.
Viscidi RP; Clayman B
Adv Exp Med Biol; 2006; 577():73-84. PubMed ID: 16626028
[TBL] [Abstract][Full Text] [Related]
17. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
Rollison DE; Helzlsouer KJ; Halsey NA; Shah KV; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1448-52. PubMed ID: 15941954
[TBL] [Abstract][Full Text] [Related]
18. Serologic evidence for exposure to simian virus 40 in North American zoo workers.
Engels EA; Switzer WM; Heneine W; Viscidi RP
J Infect Dis; 2004 Dec; 190(12):2065-9. PubMed ID: 15551203
[TBL] [Abstract][Full Text] [Related]
19. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children.
Mazzoni E; Frontini F; Rotondo JC; Zanotta N; Fioravanti A; Minelli F; Torreggiani E; Campisciano G; Marcuzzi A; Guerra G; Tommasini A; Touzé A; Martini F; Tognon M; Comar M
J Cell Physiol; 2019 Apr; 234(4):3170-3179. PubMed ID: 30362540
[TBL] [Abstract][Full Text] [Related]
20. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults.
Jafar S; Rodriguez-Barradas M; Graham DY; Butel JS
J Med Virol; 1998 Apr; 54(4):276-84. PubMed ID: 9557293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
